Trials / Unknown
UnknownNCT05992987
Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
adenosine deaminase activity (ADA) has been reported to be elevated in various diseases such as psoriasis, acne and juvenile idiopathic arthritis. There is no previous studies that assessed ADA in chronic spontaneous urticaria (CSU) .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Adenosine deaminase serum level | Adenosine deaminase will be measured by enzymatic (clorometric / kinetic) method (Diazyme laboratories, San Diego, California, USA). |
| DIAGNOSTIC_TEST | IgE antibodies serum level | Level of IgE will be measured by electrochemiluminesence immunoassay (ECLIA, automatic cobase immunoassay, Roche Diagnostics GmbH, Mannheim, USA). |
Timeline
- Start date
- 2023-08-15
- Primary completion
- 2023-12-31
- Completion
- 2024-03-31
- First posted
- 2023-08-15
- Last updated
- 2023-08-15
Source: ClinicalTrials.gov record NCT05992987. Inclusion in this directory is not an endorsement.